Metronidazole Benzoate

苯酰甲硝唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMetronidazole Benzoate
Drug Alias Name甲硝唑苯甲酸酯灭滴灵
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSusceptible anaerobic bacteria infectionTrichomonas VaginitisLeishmaniasis, Cutaneous +[7] 
Global Approved IndicationsSusceptible anaerobic bacteria infectionTrichomonas VaginitisLeishmaniasis, Cutaneous +[7] 
Approved Indications in ChinaSusceptible anaerobic bacteria infectionTrichomonas VaginitisLeishmaniasis, Cutaneous +[7] 
Original Approved Country/TerritoryMainland China
Original Approved Date2002/11/26
Country/TerritorySwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTillotts Pharma Ag
Active IndicationsSusceptible anaerobic bacteria infectionTrichomonas VaginitisLeishmaniasis, Cutaneous +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG